Mein Warenkorb

MMP-9

MMP-9 Molekülinformation

Englischer NameMatrix metalloproteinase 9Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3Target-AliasType V Collagenase,Gelatinase B,EC 3.4.24.35,MANDP2,Matrix Metalloproteinase 9,CLG4B,MMP9,Matrix Metallopeptidase 9,Matrix Metalloproteinase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),GELB,Matrix Metalloproteinase-9,92 KDa Type IV Collagenase,Macrophage Gelatinase,92 kDa gelatinase,MMP-9,Matrix Metallopeptidase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),EC:3.4.24.35,EC 3.4.24
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Englischer NameMatrix metalloproteinase 9
Target-AliasType V Collagenase,Gelatinase B,EC 3.4.24.35,MANDP2,Matrix Metalloproteinase 9,CLG4B,MMP9,Matrix Metallopeptidase 9,Matrix Metalloproteinase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),GELB,Matrix Metalloproteinase-9,92 KDa Type IV Collagenase,Macrophage Gelatinase,92 kDa gelatinase,MMP-9,Matrix Metallopeptidase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),EC:3.4.24.35,EC 3.4.24
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical

MMP-9 Produktliste

  • Attribut

    Protein (6)

  • Produktbibliothek

    Online (6)

  • Spezies

    Human (4)Mouse (1)Cynomolgus (1)

  • Etikett

    His Tag (6)

  • Marker

    Unconjugated (6)

MMP-9 Molekülhintergrund

Matrix metallopeptidase 9 (MMP-9) is also known as 92 kDa type IV collagenase, 92 kDa gelatinase or gelatinase B (GELB), CLG4B, is secreted from neutrophils, macrophages, and a number of transformed cells, and is the most complex family member in terms of domain structure and regulation of its activity. . Structurally, MMP9 maybe be divided into five distinct domains: a prodomain which is cleaved upon activation, a gelatinbinding domain consisting of three contiguous fibronectin type II units, a catalytic domain containing the zinc binding site, a prolinerich linker region, and a carboxyl terminal hemopexinlike domain. This enzyme degrades various substrates including gelatin, collagen types IV and V, and elastin. MMP9 is involved in a variety of autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis, and be regarded as a potential therapeutic target.

MMP-9 Molekülalias

MMP9,CLG4B,GELB,MANDP2,Gelatinase B

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
AndecaliximabGS-5745Phase 3 ClinicalGilead IncArthritis, Rheumatoid; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Cystic Fibrosis; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Myositis Ossificans; Ossification, Heterotopic; Pancreatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Spinal Cord Injuries; Stomach Neoplasms
Details
AQU-005AQU-005; NMAQU-005; NM-AQU-005Phase 1 ClinicalAquilus PharmaceuticalsNeuralgia
Details
CALY-001CALY-001ClinicalCalypso Biotech BvCrohn Disease; Inflammatory Bowel Diseases
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns